Structural similarities between SARS-CoV2 3CLpro and other viral proteases suggest potential lead molecules for developing broad spectrum antivirals
Considering the significant impact of the recent COVID-19 outbreak, development of broad-spectrum antivirals is a high priority goal to prevent future global pandemics. Antiviral development processes generally emphasize targeting a specific protein from a particular virus. However, some antiviral a...
Main Authors: | Khushboo Bafna, Christopher L. Cioffi, Robert M. Krug, Gaetano T. Montelione |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fchem.2022.948553/full |
Similar Items
-
Protocol for production and purification of SARS-CoV-2 3CLpro
by: Luca Mazzei, et al.
Published: (2023-06-01) -
Dendrogramic Representation of Data: CHSH Violation vs. Nonergodicity
by: Oded Shor, et al.
Published: (2021-07-01) -
Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease
by: Yi Kuang, et al.
Published: (2023-04-01) -
A topology optimisation-based design method for 3D Voronoi porous structures and its application for medical pillows
by: Bo Liu, et al.
Published: (2023-12-01) -
Virtual screening of flavonoids as potential RIPK1 inhibitors for neurodegeneration therapy
by: Asim Kumar Bepari, et al.
Published: (2024-01-01)